Navigation Links
Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma
Date:9/8/2009

LONDON, Sept. 8 /PRNewswire/ -- The 2009 Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award is presented to Pronova BioPharma ASA. The company's first commercialised product is the first and only EU-and FDA-approved omega-3 derived prescription drug. Branded Omacor in Europe and Asia and Lovaza in the USA, the product is a prescribed adjunct to diet for the treatment of elevated levels of triglycerides in humans. In addition, Omacor/Lovaza has the approval in certain markets for treatment of the secondary prevention of post-myocardial infarction.

(Logo:http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Pronova BioPharma has demonstrated excellence in financial management. The growth in sales in 2008 as compared to 2007 was 28.3 per cent. The company witnessed a growth of 38.5 per cent in 2009 Q1 over 2008 Q1. The total production of active pharmaceutical ingredients (API) were 615 tonnes, 918 tonnes, and 1201 tonnes, while shipments were 593 tonnes, 929 tonnes, and 1185 tonnes in 2006, 2007, and 2008, respectively. The growth in production and shipment is phenomenal and is reflective of the strong demand for Omacor/Lovaza.

Pronova BioPharma's return on assets (ROA) improved from 16.8 per cent in 2007 to 34.5 per cent in 2008. This was based on continued strong growth and commercial progress, further efficiency improvements and optimisation of manufacturing facilities at the Sandefjord plant.

"The company has dramatically improved its return on equity (ROE) and return on capital employed (ROCE) over the years 2006 to 2008; in 2006, the ROCE and ROE were a negative 3.2 per cent and negative 4.4 per cent respectively, improving to 11.2 per cent and 34.5 per cent respectively in 2008," said Shrik
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan
2. Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market, Notes Frost & Sullivan
3. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
4. Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award
5. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
6. Frost & Sullivan: Growing Healthcare Tourism in Malaysia
7. A Wound that Does Not Heal: Frost & Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System
8. Frost & Sullivan: Malaysia Diagnostics and Devices Industry Outlook 2009
9. Frost & Sullivan: Medico Legal Implications Related to the Usage of Electronic Health Record
10. Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan
11. Frost & Sullivan: Outsourcing/Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...wire/--CortivaInstituteTucsonwillhostanIntroductio...attheschool,s6390EastBroadwayBlvd.location,whichwi...cticebasicmassagestrokes. ,, "Massagetherapyisa...talongwithit,"saidJoannMcMaster,presidentofCortiva...abor,s2009-2010OccupationalOutlookHandbookstatesth...
(Date:11/23/2009)...ewswire/--InasurveyofNewJerseyandPhiladelphiaregio...,72percentdonotbelieveanewhealthcarebillwouldlikel...oresultsofthelatestsurveyconductedbytheAlloySilver...toppedthelistat85percentasthebiggestnationalissue....nttocompaniesfromallpartsofNewJerseyandSoutheaster...
(Date:11/23/2009)...ience Writings at Stevens Institute of Technology ...ert Wright, journalist and founder, Bloggingheads.... the Babbio Center for Technology Management, Room... the media., In his new book "The Evolution of G...owned for his popular works on evolutionary psycho...
(Date:11/23/2009)...l errors self-reported by American surgeons are st...se findings appear today in the online edition of ...luded collaborators from Johns Hopkins and the Ame...ial study, nearly 9 percent of U.S. surgeons respo...nths prior to being surveyed. Over 70 percent attr...
(Date:11/23/2009)...s Diseases Society of America (IDSA) has asked for...e European Union to further the Society,s mission ...ithin the next 10 years, known as the 10 x ,20 Ini...identified antimicrobial resistance as one of the ...European Union report confirms there are just 15 a...
Breaking Medicine News(10 mins):Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3
... molecule that is part of a complex signaling netw...e in periventricular heterotopia (PVH), a congenit...earchers report in Neuron. PVH often leads t...ses, but is most commonly due to mutations in the ...
...tarbucks are now determined to stop the use of dai...th hormone (rBGH) at all of their stores. //Severa... cream, eggnog etc., which contain rBGH are no lon...BGH milk products to eliminate trans-fatty acids f...
... recent research finding indicates that patients w...er rate of relapse of multiple sclerosis (MS). Mul...rms the myelin sheath that covers the nerve fibres...als of Neurology. A study was conducted by them am...
...t is an act of gratitude, and Nathan Hartley is on...s one of four brothers, all who had been diagnosed...are genetic defect, in November 2003. X-linked...ses the immune system to respond abnormally to som...
...anadian scientists claim to have found a substitut...bearable side effects like nausea and fatigue. The...ournal Cancer Cell. // The scientists seemed to...and consumed. The greater advantage of DCA is its ...
... new surgical technique pioneered at the Universit... to patients with tongue cancer.// By modify...from a patient's forearm to his tongue, surgeons c...along with the tissue and skin of the forearm to r...
Other Medicine News:Health News:Missing Molecule Has Important Role in a Developmental Brain Abnormality 2Health News:Big Brother to the Rescue 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 3
(Date:11/23/2009)...23/PRNewswire-FirstCall/--WoundManagementTechnolog...viderofspecialtymedicalproducts,announcedthatithas...hensivemanagementbusinessupdatetoillustratethedeve...lesincreased33.5%to$102,926vs.Q32008salesof$77,084...$3,327,892vs.Q32008shareholderequityof$(321,257) ...
(Date:11/23/2009)...wswire-FirstCall/--CordBloodAmerica,Inc.(OTCBullet...ationcompany( http://www.cordblood-america.com )fo...biologicalinsurancepolicy,tofamiliesnationwideandi...interviewwithCEOandco-founderMatthewSchisslerisnow...ip.tv/file/2875811 . ,, Intheinterview,Mr.Schis...
(Date:11/23/2009).../PRNewswire-FirstCall/--RaptorPharmaceuticalCorp.(...edthepresentationofclinicaltrialdataonNGX426,theCo...eceptorantagonist,atthe12thInternationalConference...nNovember20-21inSanFrancisco.Theresultsofthestudyl...logyattheCenterforPainMedicineoftheUniversityofCal...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5No major role for fish in the prevention of heart failure 58482 1No major role for fish in the prevention of heart failure 58482 2No major role for fish in the prevention of heart failure 58482 3Combining sun sand and science in the Bahamas 10172 1Combining sun sand and science in the Bahamas 10172 2Combining sun sand and science in the Bahamas 10172 3Spallation Neutron Source first of its kind to reach megawatt power 10168 1Spallation Neutron Source first of its kind to reach megawatt power 10168 2
...to Meet Pace of Innovations and a Health Conscious...SNewswire/ -- The Food,and Drug Administration (FD...he history of healthcare, Commissioner Andrew von,... Institute,s 50th,Annual Conference April 12 in Be...ys to use its limited,financial and personnel reso...
...a 24 April 2007. Giaconda Ltd (ASX: GIA) today,ann...DA) has,approved the Company,s Investigational New...nt of MyocondaR to treat patients with,Crohn,s Dis...erculosis (MAP). , ,The Company understands that i...o be submitted to the FDA for this indication. The...
Other Medicine Technology:FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: